Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Normal immune function in centroblastic-centrocytic and centroblastic lymphoma].

V Weisbach1, T Zeiler, J Zingsem

  • 1Abteilung Innere Medizin, Universitätsklinikum Rudolf Vierchow-Standort Charlottenburg, Freie Universität Berlin.

Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recruiting refugees and migrants as potential hematopoietic stem cell donors to serve patients of comparable ethnicities with rare human leucocyte antigen patterns - The BluStar.NRW project in North Western Germany.

Transplant immunology·2024
Same author

Identification of the novel allele, HLA-A*01:234, in the mother of a German cord blood donor.

HLA·2018
Same author

Identification of the novel allele, HLA-C*01:136 in a German cord blood donor originating from Azerbaijan.

HLA·2018
Same author

Change of the metabolomic profile during short-term mononuclear cell storage.

Vox sanguinis·2017
Same author

Influence of early irradiation on in vitro red blood cell (RBC) storage variables of leucoreduced RBCs in additive solution SAG-M.

Vox sanguinis·2015
Same author

T-cell subsets in autologous and allogeneic peripheral blood stem cell concentrates.

Vox sanguinis·2015
Same journal

[Not Available].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Preliminary results of the 2nd multicenter study. Thrombocytapheresis with the Fresenius AS-104 blood cell separator and ring study of cell counting. Section of Therapeutic and Preparative Hemapheresis of the DGTI].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Thrombocyte substitution in hematologic patients].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Substitution of thrombocyte concentrates in polytransfused patients].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Indications for fresh frozen plasma: evaluation of virus inactivating preparations].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
Same journal

[Indications for irradiated blood components: dose and side effects].

Beitrage zur Infusionstherapie = Contributions to infusion therapy·1993
See all related articles

Patients with centroblastic-centrocytic lymphoma and centroblastoma exhibit low, yet normal, in vitro immune function. Their lymphocyte reactivity mirrors that of healthy individuals with the lowest immune response.

Area of Science:

  • Immunology
  • Oncology
  • Hematology

Context:

  • Investigating immune system function in patients with non-Hodgkin lymphomas.
  • Evaluating lymphocyte reactivity, cell counts, and granulocyte function.
  • Utilizing cluster analysis to define distinct immune response profiles in healthy controls.

Purpose:

  • To compare the in vitro immune function of patients with centroblastic-centrocytic lymphoma (CB-CC) and centroblastoma (CB) against healthy controls.
  • To assess lymphocyte reactivity, lymphocyte subpopulations, and granulocyte functions in lymphoma patients.

Summary:

  • In vitro lymphocyte reactivity, lymphocyte counts, and granulocyte functions were measured in 88 healthy controls and patients with CB-CC (n=10) and CB (n=7).
  • Healthy controls were categorized into high, medium, and low responders based on lymphocyte reactivity.

Related Experiment Videos

  • Both CB-CC and CB patients demonstrated lymphocyte reactivity comparable to the low-responding control group, indicating a low but normal in vitro immune function.

    • Impact:

    • Reveals that specific malignant lymphomas present with immune function equivalent to low-responding healthy individuals.
    • Provides insights into the immunodeficiency associated with CB-CC and CB lymphomas.
    • Highlights the importance of comparing patient immune profiles to distinct control group clusters for accurate assessment.